Tumour-associated and non-tumour-associated microbiota: Addendum

被引:26
|
作者
Flemer, Burkhardt [1 ,2 ,3 ]
Herlihy, Maeve [4 ]
O'Riordain, Micheal [4 ]
Shanahan, Fergus [1 ,4 ]
O'Toole, Paul W. [1 ,2 ,3 ]
机构
[1] APC Microbiome Inst, Cork, Ireland
[2] Sch Microbiol, Cork, Ireland
[3] Sch Med, Cork, Ireland
[4] Natl Univ Ireland, Univ Coll Cork, Sch Med, Galway, Ireland
基金
爱尔兰科学基金会;
关键词
colorectal cancer; gut microbiota; survival;
D O I
10.1080/19490976.2018.1435246
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In a recent study(1) we reported that tissue-associated microbial Co-abundance Groups (CAGs) were differentially associated with colorectal cancer (CRC). Two of the CAGs, which we named Pathogen CAG and Prevotella CAG, were correlated with a gene expression signature indicative of a TH17 response. A TH17 response has been associated with decreased survival in patients with CRC2, and members of the Pathogen CAG such as Fusobacterium nucleatum, Escherichia coli and Bacteroides fragilis have been repeatedly reported to be associated with CRC-development. Thus we hypothesized that the abundance of these CAGs may be associated with poor survival. In this Addendum we extend our analysis of the at-surgery microbiota to microbiota profiles obtained after surgery for CRC which we analyzed in the context of survival data for patients with CRC. Surprisingly we found that high tissue-associated abundance of the previously defined Prevotella- and Pathogen-CAGs at surgery was associated with longer survival. Furthermore, we detected an association of the Bacteroidetes CAG in pre-surgery faecal microbiota with stability of the microbiota after surgery.
引用
收藏
页码:369 / 373
页数:5
相关论文
共 50 条
  • [21] Tumour-associated antigens in multiple myeloma
    Pellat-Deceunynck, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (01) : 3 - 9
  • [22] Targeting Tumour-Associated Fibroblasts in Cancers
    Shah, Kairav
    Mallik, Sanchari Basu
    Gupta, Praveer
    Iyer, Abishek
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] Tumour Biology: Tumour-associated Inflammation versus Antitumor Immunity
    Mueller-Huebenthal, Boris
    Azemar, Marc
    Lorenzen, Dirk
    Huber, Michael
    Freudenberg, Marina A.
    Galanos, Chris
    Unger, Clemens
    Hildenbrand, Bernd
    [J]. ANTICANCER RESEARCH, 2009, 29 (11) : 4795 - 4805
  • [24] Clinical relevance of tumour-associated macrophages
    Pittet, Mikael J.
    Michielin, Olivier
    Migliorini, Denis
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (06) : 402 - 421
  • [25] Tumour-associated neutrophils in patients with cancer
    Merav E. Shaul
    Zvi G. Fridlender
    [J]. Nature Reviews Clinical Oncology, 2019, 16 : 601 - 620
  • [26] Clinical relevance of tumour-associated macrophages
    Mikael J. Pittet
    Olivier Michielin
    Denis Migliorini
    [J]. Nature Reviews Clinical Oncology, 2022, 19 : 402 - 421
  • [27] Tumour-associated neutrophils in patients with cancer
    Shaul, Merav E.
    Fridlender, Zvi G.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (10) : 601 - 620
  • [28] Characteristics of brain tumour-associated headache
    Schankin, C. J.
    Ferrari, U.
    Reinisch, V. M.
    Birnbaum, T.
    Goldbrunner, R.
    Straube, A.
    [J]. CEPHALALGIA, 2007, 27 (08) : 904 - 911
  • [29] Brain tumour-associated status epilepticus
    Goonawardena, Janindu
    Marshman, Laurence A. G.
    Drummond, Katharine J.
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (01) : 29 - 34
  • [30] Molecular Repolarisation of Tumour-Associated Macrophages
    van Dalen, Floris J.
    van Stevendaal, Marleen H. M. E.
    Fennemann, Felix L.
    Verdoes, Martijn
    Ilina, Olga
    [J]. MOLECULES, 2019, 24 (01):